Industrial digitalisation

Digitalisation – A land of opportunities for the tissue industry

Written by Marika Hahtala

Digitalisation – A land of opportunities for the tissue industry

Industrial digitalisation will revolutionise the tissue industry. New tools and technologies will help to create the next level of efficient and sustainable tissue production. Industrial digitalisation, or Industry 4.0, is often described as a knight in shining armour – a solution for everything – but what is behind the armour and what strength is hidden underneath?

Tissue products are essential products for most humans – they are diverse and range from specialised products to commodity ones. Both efficient production and especially logistics are essential in this largely margin-based business. At the production sites, tissue producers are constantly trying to improve margins by improving equipment availability, optimising product quality, and reducing cost by efficient use of raw materials, equipment, and transportation throughout its value chain.

The name of the game

The overall objective is normally the constant tuning of all parameters to get a minor improvement here and there. This method has historically been used and still is today as tissue producers have done this effectively for many years. The challenge is that the opportunities for efficiency improvement has been reduced as things are more and more efficient already. However, the need for more efficient production has not reduced. On the contrary, the increasing need for sustainable production has pushed the envelope.

Another challenge in tissue operations is the bulky nature of the tissue products which results in a need to be close to consumers in order to have efficient logistic operations. However, the diverse product palette would mean that many different products need to be produced locally and production efficiency combined with wide product portfolio seldom go together. Hence, there is a need for tissue producers to optimise their product portfolios between different production sites. There needs to be a balance between production assets, long and short-term market demand, and logistics costs.

Right on time

Speed is an important factor in the tissue value chain and value chain actors are striving to minimise storage. This means that a well-functioning supply chain and logistics operation are of key importance. By minimising storage, actors also minimise the capital bound in the supply chain. However, traditional supply chain management and order handling might not be enough to enable right-on-time deliveries. One issue is the time itself as it takes time to handle orders and to load and ship items. Additionally, since there are often several actors involved in the value chain, transparency is an issue as the actors often operate in different system environments. By establishing systems to share information between actors, many hurdles could be removed and would, for example, enable production planning based on consumption in a more direct manner.

An increased level of transparency would also enable better traceability throughout the value chain. For instance, this would make it easy to remove items from the shelves if a serious error has been detected in the production. Even though some producers have traceability in place, it is not to such a high level and is often more manual and not visible in the value chain. However, it is seldom the case that traceability is established before the tissue machine and includes pulps and pulp producers. This is an issue as pulp often is purchased on the spot market and quality may differ between suppliers.

The knight in shining armour - digitalisation

Industrial digitalisation, or Industry 4.0, is often described as a knight in shining armour – a solution for everything – but what is behind the armour and what strength is hidden underneath? To understand the potential that industrial digitalisation offers, it helps to understand that there is much to gain from taking advantage of data that is produced in production processes and logistic chains. Naturally, this is already done today but for any process in the tissue industry, for instance, it is only a small fraction of all data used. Hence, there is much more data which can be utilised. Another issue is when the data is used and by whom. In many cases the person that needs the data to make a decision does not have the data available when the decision needs to be taken. Also, the amount of data available is part of the challenge. How can we find the golden needle in the haystack and what information is affecting our process? It is here that Industry 4.0 approaches come into play. New technologies like big data, artificial intelligence, machine learning, Internet of things (IoT), 5G, and cloud solutions are all part of the new Industry 4.0 toolbox that gives brands new ways to access and use data to meet the tissue industry’s needs.

It is all about data

Considering the challenges that come with data, it is obvious that a lot can be done – things that were not possible only a few years ago. If we start from the beginning, data needs to be generated and the need to connect many things increases. IoT is a term often used. In a scenario where more and more sensors are being used, the demand for new connectivity solutions increases. Suddenly, wired communication and WiFi is not enough and we need to look for mobile connectivity solutions. The new-coming technology in this area is 5G, which offers the industry a fast, safe, and robust connectivity solution. So, connectivity is important but then we also need to efficiently store and process all the data produced, which is not as easy as it seems. In any process industry there are a lot of operational technology (OT) systems to control and monitor the processes (some examples are PLC, DCS, SCADA). On top of those, there are manufacturing management systems (MES and MOM) and on the enterprise level we have business-IT systems such as ERP, maintenance, and CRM. Today, there are standards that suggest how these systems can be connected. However, a lot of the data is produced in the engineering systems in the design phase of a site. This data is seldom connected to the IT and OT systems, which is a shame as this would cover all information that governs a business and operation.

With all the data in one place, new technologies can be used to learn from the data. Different types of artificial intelligence (AI) and machine learning (ML) technologies can be utilised to develop complex models that describe processes and enable prediction of future behaviour. These technologies are relatively new and still exotic in the tissue industry but are already a commodity in the retail and bank sectors to name a few. In the process industry, these technologies are especially interesting as there is the possibility to change maintenance regime from a preventive maintenance to a predictive maintenance. This in turn makes the whole maintenance more cost efficient and improves equipment availability. They also enable different kinds of process optimisation.

A land of opportunities

So, what can tissue producers gain from applying Industry 4.0 technologies in their operation? There are naturally plenty of opportunities but to give an indication, some important areas are listed here.

  • Establish interoperability between business-IT systems, operational systems, and engineering systems for the whole life-time of a site.
  • Establish a cross-site data management system
  • Optimised supply chain by establishing systems for data management cross actors in a value chain or an ecosystem
  • Develop a clear digital roadmap from current status to future situation
  • Develop value creating modules utilizing advanced data analytics (e.g. AI and ML) to optimise production and maintenance

Therefore, industrial digitalisation offers a range of new tools for the tissue industry to reach new heights in terms of efficiency, sustainability, and control. However, this is not a quick fix that takes care of everything overnight. Instead, it is a process composed of several building blocks that improves operations step by step in a similar fashion to how tissue producers are already working. However, the tools are different and new knowledge might be needed in order to take advantage of the digital tools. AFRY, as the leading consultant in the pulp and paper industry, is more than ready to help tissue producers in this digital transformation.  


Written By

Mikael Ankerfors, COO of AFRY X

Fabian Lyman - Head of Sales, Digital Services

Fabian Lyman

Head of Sales, Digital Services

Contact Fabian Lyman

For sales enquiries, please complete this form. For all other enquiries, please visit our office and contacts page here.
Kai Vikman - Chief Operating Officer, Process Industries Division

Kai Vikman

Chief Operating Officer, Process Industries Division

Contact Kai Vikman

For sales enquiries, please complete this form. For all other enquiries, please visit our office and contacts page here.

Read the full article

This is a shortened article published originally in TissueMag.